Molzym Announces Double-Digit Million EUR Capital Increase

07-Jul-2022 - Molzym is proud to announce a double-digit million EUR investment by a large single family office. The capital will be deployed for the international business expansion, in particular for market entry and expansion in the US and China as well as further expanding its presence in Europe. ...

Molzym is Part of Gradian Diagnostics

11-Feb-2020 - Gradian Diagnostics announced that Molzym GmbH & Co. KG is joining Gradian Diagnostics. Molzym will become the first acquisition, bringing a wide set of products and services due to their wealth of experience and expertise in molecular microbial analysis, and their focus on deep research and ...

Molzym Automated Pathogen Enrichment and PCR Test Gets CE Mark for In Vitro Diagnostics

15-Nov-2017 - Molzym announces CE IVD marking of their robotic microbial DNA isolation and direct PCR test, Micro-Dx™, for routine pathogen diagnosis. With Micro-Dx™ Molzym introduces its latest development of products in line with SepsiTest™-UMD which was released in 2008. “By Molzym’s proprietary robotic DNA ...

Seegene and Molzym partner on automated molecular sepsis diagnostics

28-Mar-2011 - Seegene and Molzym announced a partnership on the automated Magicplex™ Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens. "The Magicplex Sepsis Test will be the new gold standard for performing accurate, rapid and ...

Researchers identify non-culturable microbes from bloodstream infections

15-Feb-2011 - Molzym has developed in collaboration with NorDiag ASA the first automated platform worldwide for the culture-independent universal identification of microorganisms from whole blood. Clinical studies have shown that a high proportion of microbial infections are not detectable by conventional ...

Cooperation between NorDiag and Molzym

19-Feb-2010 - NorDiag and Molzym have now succeeded to combine their respective technologies into an integrated system for automated molecular detection of pathogens, among others for sepsis testing. Following this milestone, the two companies have signed a firm collaboration agreement regarding sale of an ...

NorDiag enters distribution and collaboration agreement with Molzym

22-Oct-2008 - NorDiag has entered into two distribution agreements with German based Molzym GmbH & Co KG covering Molzym’s molecular diagnostic products. The first agreement is geographically restrained to USA and Canada, while the second agreement covers the Nordic countries. NorDiag has also entered into a ...

Sepsis: Broad-spectrum PCR-Test receives CE-IVD approval

Groundbreaking test enables rapid and reliable routine diagnostics

01-Oct-2008 - SepsiTest™ is a novel PCR test for early and rapid diagnosis of sepsis. In less than four hours the broad-spectrum screening assay detects more than 345 relevant sepsis germs. Today’s conventional microbiological methods usually deliver results, on an average, only after 48 hours. SepsiTest™ ...